- KASL clinical practice guidelines: management of hepatitis C
-
The Korean Association for the Study of the Liver (KASL)
- KMID: 2363030
- Clin Mol Hepatol.
- 2016 Mar;22(1):76-139.
- doi: 10.3350/cmh.2016.22.1.76
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- KASL clinical practice guidelines: management of chronic hepatitis B
-
The Korean Association for the Study of the Liver (KASL)
- KMID: 2363029
- Clin Mol Hepatol.
- 2016 Mar;22(1):18-75.
- doi: 10.3350/cmh.2016.22.1.18
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Intraductal malignant tumors in the liver mimicking cholangiocarcinoma: Imaging features for differential diagnosis
-
Kim AY, Jeong WK
- KMID: 2363040
- Clin Mol Hepatol.
- 2016 Mar;22(1):192-197.
- doi: 10.3350/cmh.2016.22.1.192
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Liver metastasis of meningeal hemangiopericytoma: a study of 5 cases
-
Lo RC, Suriawinata AA, Rubin BP
- KMID: 2363039
- Clin Mol Hepatol.
- 2016 Mar;22(1):188-191.
- doi: 10.3350/cmh.2016.22.1.188
Mesenchymal tumors in the liver, whether primary or metastatic, are rare. Meningeal hemangiopericytoma (HPC) is characteristically associated with delayed metastasis and the liver is one of the most common sites.... -
- CITED
-
- Close
- SHARE
-
- Close
- A concise review of updated guidelines regarding the management of hepatocellular carcinoma around the world: 2010-2016
-
Yu SJ
- KMID: 2363028
- Clin Mol Hepatol.
- 2016 Mar;22(1):7-17.
- doi: 10.3350/cmh.2016.22.1.7
Many guidelines for hepatocellular carcinoma (HCC) have been published and updated globally. In contrast to other cancers, there is a range of treatment options for HCC involving several multidisciplinary care... -
- CITED
-
- Close
- SHARE
-
- Close
- Primary squamous cell carcinoma of the liver: a case report
-
Yoo TK, Kim BI, Han EN, Kim DH, Yoo JH, Lee SJ, Cho YK, Kim HJ
- KMID: 2363037
- Clin Mol Hepatol.
- 2016 Mar;22(1):177-182.
- doi: 10.3350/cmh.2016.22.1.177
Primary squamous cell carcinoma (SCC) of the liver is very rare, and few cases have been reported in Korea. Primary SCC of the liver is known to be associated with... -
- CITED
-
- Close
- SHARE
-
- Close
- Acute-on-chronic liver failure: a new syndrome in cirrhosis
-
Moreau R
- KMID: 2363027
- Clin Mol Hepatol.
- 2016 Mar;22(1):1-6.
- doi: 10.3350/cmh.2016.22.1.1
Patients with cirrhosis who are hospitalized for an acute decompensation (AD) and also have organ failure(s) are at high risk of short-term death. These patients have a syndrome called Acute-on-Chronic... -
- CITED
-
- Close
- SHARE
-
- Close
- Portal biliopathy treated with endoscopic biliary stenting
-
Jeon SJ, Min JK, Kwon SY, Kim JH, Moon SY, Lee KH, Kim JH, Choe WH, Cheon YK, Kim TH, Park HS
- KMID: 2363036
- Clin Mol Hepatol.
- 2016 Mar;22(1):172-176.
- doi: 10.3350/cmh.2016.22.1.172
Portal biliopathy is defined as abnormalities in the extra- and intrahepatic ducts and gallbladder of patients with portal hypertension. This condition is associated with extrahepatic venous obstruction and dilatation of... -
- CITED
-
- Close
- SHARE
-
- Close
- Regression of esophageal varices during entecavir treatment in patients with hepatitis-B-virus-related liver cirrhosis
-
Jwa HY, Cho YK, Choi EK, Kim HU, Song HJ, Na SY, Boo SJ, Jeong SU, Kim BS, Lee BW, Song BC
- KMID: 2363038
- Clin Mol Hepatol.
- 2016 Mar;22(1):183-187.
- doi: 10.3350/cmh.2016.22.1.183
Recent studies suggest that liver cirrhosis is reversible after administering oral nucleos(t)ide analogue therapy to patients with hepatitis B virus (HBV) infection. However, few studies have addressed whether esophageal varices... -
- CITED
-
- Close
- SHARE
-
- Close
- The serum vitamin D level is inversely correlated with nonalcoholic fatty liver disease
-
Chung GE, Kim D, Kwak MS, Yang JI, Yim JY, Lim SH, Itani M
- KMID: 2363032
- Clin Mol Hepatol.
- 2016 Mar;22(1):146-151.
- doi: 10.3350/cmh.2016.22.1.146
BACKGROUND/AIMS: A low vitamin D level has been associated with metabolic syndrome and diabetes. However, an association between a low vitamin D level and nonalcoholic fatty liver disease (NAFLD) has... -
- CITED
-
- Close
- SHARE
-
- Close
- Acute pancreatitis associated with pegylated interferon-alpha-2a therapy in chronic hepatitis C
-
Choi JW, Lee JS, Paik WH, Song TJ, Kim JW, Bae WK, Kim KA, Kim JG
- KMID: 2363035
- Clin Mol Hepatol.
- 2016 Mar;22(1):168-171.
- doi: 10.3350/cmh.2016.22.1.168
Chronic hepatitis C virus (HCV) infection is a major cause of liver cirrhosis and hepatocellular carcinoma. Combination therapy of pegylated interferon-alpha (PEG-IFN-α) and ribavirin (RBV) is a current standard treatment... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of tenofovir plus lamivudine versus tenofovir monotherapy in patients with lamivudine-resistant chronic hepatitis B
-
Park CH, Jung SW, Shin JW, Bae MA, Lee YI, Park YT, Chung HS, Park NH
- KMID: 2363033
- Clin Mol Hepatol.
- 2016 Mar;22(1):152-159.
- doi: 10.3350/cmh.2016.22.1.152
BACKGROUND/AIMS: Tenofovir disoproxil fumarate (TDF) exhibits similar antiviral efficacy against treatment-naïve and lamivudine (LAM)-resistant chronic hepatitis B (CHB). However, there are few clinical reports on the antiviral effects of TDF-LAM... -
- CITED
-
- Close
- SHARE
-
- Close
- Magnetization-tagged MRI is a simple method for predicting liver fibrosis
-
Kim KE, Park MS, Chung S, An C, Axel L, Ergashovna RG
- KMID: 2363031
- Clin Mol Hepatol.
- 2016 Mar;22(1):140-145.
- doi: 10.3350/cmh.2016.22.1.140
BACKGROUND/AIMS: To assess the usefulness of magnetization-tagged magnetic resonance imaging (MRI) in quantifying cardiac-induced liver motion and deformation in order to predict liver fibrosis. METHODS: This retrospective study included 85 patients... -
- CITED
-
- Close
- SHARE
-
- Close
- Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis
-
Lee JM, Jang BK, Lee YJ, Choi WY, Choi SM, Chung WJ, Hwang JS, Kang KJ, Kim YH, Chauhan AK, Park SY, Tak WY, Kweon YO, Kim BS, Lee CH
- KMID: 2363034
- Clin Mol Hepatol.
- 2016 Mar;22(1):160-167.
- doi: 10.3350/cmh.2016.22.1.160
BACKGROUND/AIMS: Treating hepatocellular carcinoma (HCC) with portal vein tumor thrombosis (PVTT) remains controversial. We compared the outcomes of hepatic resection (HR), transarterial chemoembolization (TACE), and sorafenib therapy as treatments for... -
- CITED
-
- Close
- SHARE
-
- Close
